This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: peripheral arterial disease

November 2018 Br J Cardiol 2018;25:131–132

Peripheral arterial disease assessment training tool

BJC Staff

Abstract

The aid has been created by University of Huddersfield podiatry lecturer, Mr Andrew Sharpe, who has compiled a digital library of the varied sounds that can be picked up during the Doppler ultrasound procedure. Visitors to his website http://pad-database.co.uk/ can hear the sounds, which are accompanied by case histories and the information that clinicians need to make a peripheral arterial disease assessment. A team of experts – a vascular nurse, vascular podiatrist and vascular sonographer – also provide case-by-case conclusions and explain how they would proceed on the website. “The basic premise is that sound waves do not provide a

| Full text

January 2008 Br J Cardiol 2008;15:48-50

Pharmacological secondary prevention in people with peripheral arterial disease compared to thosewith coronary artery disease: a missed opportunity

Simon EJ Janes, Joe West, Brian R Hopkinson, John T Walsh

Abstract

Introduction Patients with peripheral arterial disease (PAD) have a high prevalence of modifiable risk factors for coronary artery disease (CAD).1 Consequently, they represent a suitable target for secondary prevention and there is strong evidence that this is beneficial.2–4 We aimed to establish whether people with PAD who are admitted to hospital receive equal pharmacological secondary prevention to those with CAD. Methods We prospectively recruited patients from 1st March 2003 until 1st June 2003 admitted to a vascular surgery ward (PAD) or cardiology ward (CAD) until discharge. All patients had symptomatic established disease and underw

| Full text

September 2007 Br J Cardiol 2007;14:190

REACHing for new heights in disease management

Deepak L Bhatt, P Gabriel Steg

Abstract

In this larger context, the international Reduction of Atherothrombosis for Continued Health (REACH) Registry was launched in order to study outcomes of atherothrombotic disease, risk factors for atherothrombosis, and also current treatment patterns. Already, the REACH Registry has provided insights at a global level.1 For example, under-treatment of common risk factors such as hypertension, hyperlipidaemia, and diabetes was observed in all regions included in the REACH Registry. Obesity, including morbid obesity, was highly prevalent. Multivascular disease – atherothrombosis affecting more than one arterial territory – was present in app

| Full text

September 2005 Br J Cardiol 2005;12:401-3

Peripheral arterial disease – CVD by any other name?

Sarah Jarvis

Abstract

No content available

| Full text
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now